Total Funding
57
44
Total FundingSeed raised
Growth Score 57 in past quarter
9 pts
Heat Score 44 in past quarter
29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
234237
IoTech International focuses on molecular iodine research and development.
- Edward Quilty: CEO
- Herb Moskowitz: Co-Founder and Managing Director
About the Company
IoTech International focuses on molecular iodine research and development, ushering in a new generation of advanced, patented products.
Founded on a simple principle that healthcare workers, clinicians, and patients deserved the best broad-spectrum germicidal products, IoTech International was launched.
From the start, IoTech's three
co-inventors knew of iodine's incredible power to inactivate pathogens. Building on iodine's long and well-known safety record, they set out to develop stable, high concentration molecular iodine (germ killing) formulations while eliminating the staining attributes typically associated with iodine.